Skip to content

Medical-device intelligence

SHW: Pathology Software Algorithm Device Analyzing Digital Images For Breast Cancer Prognosis

FDA product code SHW: Pathology Software Algorithm Device Analyzing Digital Images For Breast Cancer Prognosis. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
SHW
FDA device name
Pathology Software Algorithm Device Analyzing Digital Images For Breast Cancer Prognosis
Device class
2
Regulation number
864.3755
Medical specialty
Pathology
Review panel
PA

FDA definition

A pathology software algorithm device analyzing digital images for breast cancer prognosis is a software intended to analyze digital images acquired from medical imaging devices (for example but not limited to - whole slide imaging scanners). The device provides prognostic risk estimates which are intended to assist physicians with prognostic risk-based decisions along with other clinicopathological factors. The device is not intended to determine a clinical diagnosis.
Explore pathology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from May 4, 2026 to Sep 25, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202610
June 202600
July 202600
August 202600
September 202610
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

2 matching records
Device / recordCompany in FDA recordSourceSource date
TumorSight RiskK260023 · SHWSimBioSys, Inc.510(k)Sep 25, 2026FDA decision date
ArteraAI BreastK254115 · SHWArtera, Inc.510(k)May 4, 2026FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗